Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications
Web of Science
AuthorTaheri, Y; Suleria, HAR; Martins, N; Sytar, O; Beyatli, A; Yeskaliyeva, B; Seitimova, G; Salehi, B; Semwal, P; Painuli, S; ...
Source TitleBMC COMPLEMENTARY MEDICINE AND THERAPIES
University of Melbourne Author/sSuleria, Hafiz Ansar Rasul
AffiliationAgriculture and Food Systems
Document TypeJournal Article
CitationsTaheri, Y., Suleria, H. A. R., Martins, N., Sytar, O., Beyatli, A., Yeskaliyeva, B., Seitimova, G., Salehi, B., Semwal, P., Painuli, S., Kumar, A., Azzini, E., Martorell, M., Setzer, W. N., Maroyi, A. & Sharifi-Rad, J. (2020). Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications. BMC COMPLEMENTARY MEDICINE AND THERAPIES, 20 (1), https://doi.org/10.1186/s12906-020-03033-z.
Access StatusOpen Access
Several flavonoids have been recognized as nutraceuticals, and myricetin is a good example. Myricetin is commonly found in plants and their antimicrobial and antioxidant activities is well demonstrated. One of its beneficial biological effects is the neuroprotective activity, showing preclinical activities on Alzheimer, Parkinson, and Huntington diseases, and even in amyotrophic lateral sclerosis. Also, myricetin has revealed other biological activities, among them as antidiabetic, anticancer, immunomodulatory, cardiovascular, analgesic and antihypertensive. However, few clinical trials have been performed using myricetin as nutraceutical. Thus, this review provides new insights on myricetin preclinical pharmacological activities, and role in selected clinical trials.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References